Page last updated: 2024-11-05

trazodone and Movement Disorders

trazodone has been researched along with Movement Disorders in 1 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demuth, GW1
Breslow, RE1
Drescher, J1

Other Studies

1 other study available for trazodone and Movement Disorders

ArticleYear
The elicitation of a movement disorder by trazodone: case report.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:12

    Topics: Aged; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Huma

1985